Norimatsu Yoshiaki, Ohsaki Hiroyuki, Yanoh Kenji, Kawanishi Namiki, Kobayashi Tadao K
Department of Medical Technology, Ehime Prefectural University of Health Sciences, Ehime, Japan.
Diagn Cytopathol. 2013 Apr;41(4):303-7. doi: 10.1002/dc.21837. Epub 2011 Sep 26.
It is well known that "condensed cluster of stromal cells (CCSC)" and "metaplastic clumps with irregular protrusion (MCIP)" in endometrial glandular and stromal breakdown (EGBD) cases may simulate "clumps of cancer cells (CCC)" in endometrioid adenocarcinoma grade 1 (G1), leading to difficulty in cytological interpretation. The aim of this study was undertaken to clarify the cytological immunoreactivity of nuclear findings about CCSC and MCIP which may be recognized in EGBD cases by using p53 protein and cyclin A in liquid-based cytologic (LBC) preparations. The material consists of cytologic smears of 20 cases of EGBD and 20 cases of G1 for which histopathological diagnosis was obtained by endometrial curettage at the JA Suzuka General Hospital. The evaluation of immunoreactivity was performed by using the intensity of nuclear staining and the nuclear labeling index (N-LI). The intensity of nuclear staining was scored as negative (0), weak (1), moderate (2), or strong (3). The N-LI was scored as less than 10% (0), from 10 to 25% (1), from 26 to 50% (2), or greater than 50% (3). The final score was calculated of the addition of both partial scores. Results are as follows: As for the p53 protein immunoreactivity, CCC (2.4 ± 1.4) was a significantly higher value in comparison with CCSC (0) and MCIP (0.8 ± 0.4), respectively. As for the cyclin A immunoreactivity, CCC (2.8 ± 1.1) was a significantly higher value in comparison with CCSC (0) and MCIP (0.6 ± 0.5), respectively. CCSC and MCIP in EGBD are misunderstood as cellular atypia and structural atypia on occasion; but, as for results of the immunoreactivity scores of p53 protein and cyclin A in our study, it seemed that those biochemical characters proved that the biological activity level was low (or degenerative). The results of the current study demonstrated that the cytological immunoreactivity of nuclear findings by p53 and cyclin A appear to be more useful for the LBC assessment of endometrial lesions, especially for the discrimination of EGBD and G1.
众所周知,在子宫内膜腺性和间质崩解(EGBD)病例中,“基质细胞浓缩簇(CCSC)”和“伴有不规则突起的化生团块(MCIP)”可能会模拟子宫内膜样腺癌1级(G1)中的“癌细胞团块(CCC)”,从而导致细胞学解释困难。本研究的目的是通过在液基细胞学(LBC)制剂中使用p53蛋白和细胞周期蛋白A来阐明在EGBD病例中可能识别出的CCSC和MCIP核发现的细胞学免疫反应性。材料包括20例EGBD和20例G1的细胞学涂片,这些病例在JA铃鹿综合医院通过子宫内膜刮宫术获得了组织病理学诊断。免疫反应性评估通过使用核染色强度和核标记指数(N-LI)进行。核染色强度评分为阴性(0)、弱阳性(1)、中度阳性(2)或强阳性(3)。N-LI评分为小于10%(0)、10%至25%(1)、26%至50%(2)或大于50%(3)。最终得分是两个部分得分的相加。结果如下:关于p53蛋白免疫反应性,CCC(2.4±1.4)与CCSC(0)和MCIP(0.8±0.4)相比分别显著更高。关于细胞周期蛋白A免疫反应性,CCC(2.8±1.1)与CCSC(0)和MCIP(0.6±0.5)相比分别显著更高。EGBD中的CCSC和MCIP有时会被误解为细胞异型性和结构异型性;但是,就我们研究中p53蛋白和细胞周期蛋白A的免疫反应性评分结果而言,这些生化特征似乎证明其生物活性水平较低(或处于退化状态)。本研究结果表明,p53和细胞周期蛋白A对核发现的细胞学免疫反应性似乎对子宫内膜病变的LBC评估更有用,特别是对于EGBD和G1的鉴别。